|A unique collection of 71 Anti-hyperlipidemic natural compounds with biological activity of Anti-hyperlipidemic|
|Catalog No:||Bb134|| Anti-hyperlipidemic Compound Library
|Size:||1mg/well * 71 Compounds|
2mg/well * 71 Compounds
1. Gelsemine has antitumor activity.
2. Gelsemine has anti-oxidative activity.
3. Gelsemine has anti-hyperlipidemic activity.
4. Gelsemine has marked antinociception in inflammatory, neuropathic and bone cancer pains without inducing antinociceptive tolerance.
1. Iriflophenone-3- C -glucoside has antioxidant activity, it presents no radical scavenging ability against DPPH , but scavenges ABTS + and peroxyl radicals (TEAC ABTS of 1.04 and TEAC ORAC of 3.61).
2. Iriflophenone-3-C-β-d-glucoside shows potent inhibitory activity against α-glucosidase.
3. Iriflophenone 3-C-β-D-glucoside and mangiferin which along with 3 β taraxerol and other sterols could be contributing to the cholesterol lowering activity.
Fraxetin has dual-antioxidative ,hepatoprotective and antihyperglycemic functions, it shows potent protective effects against CCl4 induced oxidative stress and hepatic fibrosis, has a marked inhibitory effect on S.aureus proliferation. It increased the level of Nrf2/ARE, and HO-1, inhibit the formation of ROS, cytochrome c release, activation of caspase-3 and 9, and suppressed the up-regulation of Bax.
Genipin is an excellent natural cross-linker for proteins, collagen, gelatin, and chitosan cross-linking, can be used as a regulating agent for drug delivery, as the raw material for gardenia blue pigment preparation. It is a novel chemical activator of EBV lytic cycle and a cell permeable inhibitor of uncoupling protein 2 (UCP2). Genipin has antimicrobial,antiviral, antitumor, and anti-inflammatory effects, it is used for choleretic action for liver diseases control and could be used for the treatment of periodontal disease to prevent MMPs expression in periodontal lesion. It shows an antithrombotic effect in vivo due to the suppression of platelet aggregation.
1. Globularin has hypoglycaemic and hypolipidemic activities in normal and streptozotocin-induced diabetic rats.